Jaguar Health Completes Effectiveness Trial to Support FDA Approved Crofelemer for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs

April 8, 2026

CEMTREX SUBSIDIARY, INVOCON, SELECTED FOR U.S. NAVY SBIR PHASE I CONTRACT IN NAVAL MINE WARFARE

Hauppauge, NY, April 07, 2026 (GLOBE NEWSWIRE) — – Cemtrex, Inc. (NASDAQ: CETX, CETXP) today announced that its subsidiary Invocon, Inc. has been selected as an apparently successful offeror for a Phase I Small Business Innovation Research (SBIR) contract with the Naval Sea Systems Command (NAVSEA). The award, under topic N254-P02: NAVSEA Open Topic for Modular Mine […]

April 7, 2026

AI-Enhanced Robotics in Pharma Manufacturing Signals Major Efficiency, Margin Expansion Opportunities

AUSTIN, Texas, April 07, 2026 (GLOBE NEWSWIRE) — AINewsWire Editorial Coverage: Pharmaceutical manufacturing is undergoing a structural shift as regulators demand higher standards for contamination control, data integrity and operational traceability. The European Union’s revised GMP Annex 1 emphasizes minimizing human intervention and implementing a comprehensive contamination control strategy, requiring manufacturers to assess and mitigate contamination risks across […]

April 7, 2026

TransCode Therapeutics Enters into Agreements for up to $20 Million Flexible Financing, Extending Company’s Runway into Late 2027/Early 2028

BOSTON, April 7, 2026 /PRNewswire/ — TransCode Therapeutics, Inc. (NASDAQ: RNAZ, the “Company”), a clinical stage company pioneering immuno-oncology and RNA for the treatment of high risk and advanced cancer, today announced that it has entered into an agreement with an institutional healthcare investor for financing of up to $20 million. The arrangement comprises pre-paid advances of up to […]

April 7, 2026